Difference between revisions of "Asthma"
Jump to navigation
Jump to search
(Created page with "Obstructive lung disease characterized by episodic wheezing, dyspnea, and cough, that is reversible with bronchodilators. Decreased FEV1, FEV1/FVC, increased TLC, RV, normal D...") |
|||
| Line 1: | Line 1: | ||
Obstructive lung disease characterized by episodic wheezing, dyspnea, and cough, that is reversible with bronchodilators. Decreased FEV1, FEV1/FVC, increased TLC, RV, normal DLCO. FEV1 improved >12% and >200 mL with bronchodilators. Typically diagnosed in early childhood to adolescence. Risk factors include childhood eczema, cigarette smoke exposure. | Obstructive lung disease characterized by episodic wheezing, dyspnea, and cough, that is reversible with bronchodilators. Decreased FEV1, FEV1/FVC, increased TLC, RV, normal DLCO. FEV1 improved >12% and >200 mL with bronchodilators. Typically diagnosed in early childhood to adolescence. Risk factors include childhood eczema, cigarette smoke exposure. | ||
| + | |||
| + | *ABPA is diagnosed with eosinophilia, positive aspergillum skin testing, and elevated serum IgE. | ||
| + | *ABPA is treated with systemic glucocorticoids and itraconazole or voriconazole. Do '''not''' use fluconazole. | ||
Latest revision as of 17:55, 11 January 2023
Obstructive lung disease characterized by episodic wheezing, dyspnea, and cough, that is reversible with bronchodilators. Decreased FEV1, FEV1/FVC, increased TLC, RV, normal DLCO. FEV1 improved >12% and >200 mL with bronchodilators. Typically diagnosed in early childhood to adolescence. Risk factors include childhood eczema, cigarette smoke exposure.
- ABPA is diagnosed with eosinophilia, positive aspergillum skin testing, and elevated serum IgE.
- ABPA is treated with systemic glucocorticoids and itraconazole or voriconazole. Do not use fluconazole.